Cargando…

Host, parasite and drug determinants of clinical outcomes following treatment of visceral leishmaniasis: a protocol for individual participant data meta-analysis

INTRODUCTION: Visceral leishmaniasis (VL) is a parasitic disease with an estimated 30 000 new cases occurring annually. There is an observed variation in the efficacy of the current first-line therapies across different regions. Such heterogeneity could be a function of host, parasite and drug facto...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kumar, Rishikesh, Dahal, Prabin, Singh-Phulgenda, Sauman, Siddiqui, Niyamat Ali, Munir, Abdalla, Naylor, Caitlin, Wilson, James, Buck, Gemma, Rahi, Manju, Malaviya, Paritosh, Alves, Fabiana, Sundar, Shyam, Ritmeijer, Koert, Stepniewska, Kasia, Guérin, Philippe J, Pandey, Krishna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2023
Materias:	Global Health
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10618999/ https://www.ncbi.nlm.nih.gov/pubmed/37898487 http://dx.doi.org/10.1136/bmjopen-2023-074679

Ejemplares similares

Visceral Leishmaniasis in pregnancy and vertical transmission: A systematic literature review on the therapeutic orphans
por: Dahal, Prabin, et al.
Publicado: (2021)

Gender disparity in cases enrolled in clinical trials of visceral leishmaniasis: A systematic review and meta-analysis
por: Dahal, Prabin, et al.
Publicado: (2021)

Serious adverse events following treatment of visceral leishmaniasis: A systematic review and meta-analysis
por: Singh-Phulgenda, Sauman, et al.
Publicado: (2021)

Prognostic prediction models for clinical outcomes in patients diagnosed with visceral leishmaniasis: protocol for a systematic review
por: Wilson, James, et al.
Publicado: (2023)

Visceral Leishmaniasis in Rural Bihar, India
por: Hasker, Epco, et al.
Publicado: (2012)

Visceral Leishmaniasis in Muzaffarpur District, Bihar, India from 1990 to 2008
por: Malaviya, Paritosh, et al.
Publicado: (2011)

Visceral Leishmaniasis in the Muzaffapur Demographic Surveillance Site: A Spatiotemporal Analysis
por: Hasker, Epco, et al.
Publicado: (2018)

Diagnosis of Visceral Leishmaniasis in an Elimination Setting: A Validation Study of the Diagnostic Algorithm in India
por: Cloots, Kristien, et al.
Publicado: (2022)

Visceral Leishmaniasis Clinical Management in Endemic Districts of India, Nepal, and Bangladesh
por: Banjara, Megha Raj, et al.
Publicado: (2012)

The power of pooled analysis to inform optimal dosing strategies for Artemisinin Combination Therapies (ACTs)
por: Guerin, Philippe J, et al.
Publicado: (2012)

The effect of dose on the antimalarial efficacy of artesunate-mefloquine against Plasmodium falciparum malaria: a protocol for systematic review and individual patient data (IPD) meta-analysis
por: Mansoor, Rashid, et al.
Publicado: (2019)

Evaluating antimalarial efficacy in single-armed and comparative drug trials using competing risk survival analysis: a simulation study
por: Dahal, Prabin, et al.
Publicado: (2019)

Visceral Leishmaniasis and HIV Coinfection in East Africa
por: Diro, Ermias, et al.
Publicado: (2014)

Visceral leishmaniasis
por: Sundar, Shyam
Publicado: (2015)

Anticipating visceral leishmaniasis epidemics due to the conflict in Northern Ethiopia
por: Boodman, Carl, et al.
Publicado: (2023)

Visceral Leishmaniasis as an AIDS Defining Condition: Towards Consistency across WHO Guidelines
por: van Griensven, Johan, et al.
Publicado: (2014)

Visceral leishmaniasis: Spatiotemporal heterogeneity and drivers underlying the hotspots in Muzaffarpur, Bihar, India
por: Bulstra, Caroline A., et al.
Publicado: (2018)

The consequence of COVID-19 on the global supply of medical products: Why Indian generics matter for the world?
por: Guerin, Philippe J, et al.
Publicado: (2020)

Statistical methods to derive efficacy estimates of anti-malarials for uncomplicated Plasmodium falciparum malaria: pitfalls and challenges
por: Dahal, Prabin, et al.
Publicado: (2017)

Evolutionary genomics of epidemic visceral leishmaniasis in the Indian subcontinent
por: Imamura, Hideo, et al.
Publicado: (2016)

Active case detection in national visceral leishmaniasis elimination programs in Bangladesh, India, and Nepal: feasibility, performance and costs
por: Huda, M Mamun, et al.
Publicado: (2012)

The increasing incidence of visceral leishmaniasis relapse in South Sudan: A retrospective analysis of field patient data from 2001–2018
por: Naylor-Leyland, Gabriel, et al.
Publicado: (2022)

Male predominance in reported Visceral Leishmaniasis cases: Nature or nurture? A comparison of population-based with health facility-reported data
por: Cloots, Kristien, et al.
Publicado: (2020)

Dealing with indeterminate outcomes in antimalarial drug efficacy trials: a comparison between complete case analysis, multiple imputation and inverse probability weighting
por: Dahal, Prabin, et al.
Publicado: (2019)

Tuberculosis in Visceral Leishmaniasis-Human Immunodeficiency Virus Coinfection: An Evidence Gap in Improving Patient Outcomes?
por: van Griensven, Johan, et al.
Publicado: (2018)

Wuchereria bancrofti infection is associated with progression to clinical visceral leishmaniasis in VL- endemic areas in Muzaffarpur, Bihar, India
por: Singh, Abhishek Kumar, et al.
Publicado: (2023)

A clinical severity scoring system for visceral leishmaniasis in immunocompetent patients in South Sudan
por: Kämink, Suzette S., et al.
Publicado: (2017)

Outcomes of visceral leishmaniasis in pregnancy: A retrospective cohort study from South Sudan
por: Pekelharing, Judith E., et al.
Publicado: (2020)

Post kala azar dermal leishmaniasis and leprosy prevalence and distribution in the Muzaffarpur health and demographic surveillance site
por: Hasker, Epco, et al.
Publicado: (2019)

Determinants of Visceral Leishmaniasis: A Case-Control Study in Gedaref State, Sudan
por: Nackers, Fabienne, et al.
Publicado: (2015)

Accounting for False Positive HIV Tests: Is Visceral Leishmaniasis Responsible?
por: Shanks, Leslie, et al.
Publicado: (2015)

Perceptions and experiences of the public regarding the COVID-19 pandemic in Nepal: a qualitative study using phenomenological analysis
por: Bhatt, Navin, et al.
Publicado: (2020)

Does timing of antiretroviral treatment influence treatment outcomes of visceral leishmaniasis in Northwest Ethiopia?
por: Aderie, Endashaw M., et al.
Publicado: (2017)

A Systematic Literature Review of Microscopy Methods Reported in Malaria Clinical Trials
por: Das, Debashish, et al.
Publicado: (2021)

Visceral Leishmaniasis Relapse in Southern Sudan (1999–2007): A Retrospective Study of Risk Factors and Trends
por: Gorski, Stanislaw, et al.
Publicado: (2010)

Developments in Diagnosis of Visceral Leishmaniasis in the Elimination Era
por: Singh, Om Prakash, et al.
Publicado: (2015)

Strong Association between Serological Status and Probability of Progression to Clinical Visceral Leishmaniasis in Prospective Cohort Studies in India and Nepal
por: Hasker, Epco, et al.
Publicado: (2014)

Characterisation of populations at risk of sub-optimal dosing of artemisinin-based combination therapy in Africa
por: Takyi, Abena, et al.
Publicado: (2023)

Control of visceral leishmaniasis in East Africa: fragile progress, new threats
por: Dahl, Elin Hoffmann, et al.
Publicado: (2021)

Effectiveness and Safety of Short Course Liposomal Amphotericin B (AmBisome) as First Line Treatment for Visceral Leishmaniasis in Bangladesh
por: Lucero, Emiliano, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_7bl508fb550bd2r65c0jfc8ei5